Condition: GLIOMA SUSCEPTIBILITY 1
rs28933368
in
ERBB2;MIR4728
gene and
GLIOMA SUSCEPTIBILITY 1
PMID 15457249
2004 Lung cancer: intragenic ERBB2 kinase mutations in tumours.
rs1057519903
in
H3-3A
gene and
GLIOMA SUSCEPTIBILITY 1
PMID 23539269
2013 Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.
PMID 22286061
2012 Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
PMID 22286216
2012 Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
rs1057519904
in
H3C11
gene and
GLIOMA SUSCEPTIBILITY 1
PMID 22286216
2012 Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
rs1057519906
in
IDH2
gene and
GLIOMA SUSCEPTIBILITY 1
PMID 19228619
2009 IDH1 and IDH2 mutations in gliomas.
PMID 25495392
2015 IDH2 mutation in gliomas including novel mutation.
rs776893978
in
LZTR1
gene and
GLIOMA SUSCEPTIBILITY 1
PMID 30442766
2018 LZTR1 is a regulator of RAS ubiquitination and signaling.